Middlemore Hospital is a major public hospital in the suburb of Otahuhu, Auckland, New Zealand. The hospital has approximately 800 beds. There are 24 operating theatres across two sites.

During the past decade, Middlemore Hospital conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 22 clinical trials were completed, i.e. on average, 41.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Middlemore Hospital" #1 sponsor was "Boston Scientific Corporation" with 9 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 7 trials sponsored, "BeiGene" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "The George Institute" with 4 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Middlemore Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 7 trials as a collaborator, "The University of Queensland" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator and "Berry Consultants" with 2 trials as a collaborator. Other collaborators include 78 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Middlemore Hospital" are "Coronary Artery Disease" (8 trials), "Atherosclerosis" (3 trials), "Type 2 Diabetes" (3 trials), "Atherosclerosis of Native Arteries of the Extremities" (2 trials) and "Bronchiectasis" (2 trials). Many other conditions were trialed in "Middlemore Hospital" in a lesser frequency.

Most popular intervention types in "Middlemore Hospital" are "Drug" (57 trials), "Device" (15 trials), "Other" (13 trials), "Procedure" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "ARO-APOC3" (2 trials), "Aspirin" (2 trials), "BGB-11417" (2 trials) and "Carfilzomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Middlemore Hospital" are 82 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Middlemore Hospital". undefined are not yet recruiting, 13 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Middlemore Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Middlemore Hospital, 11 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 16 trials that are defined as “Not Applicable".